HHS Secretary Azar Praises New FDA Actions to Promote Generic Competition and Lower Drug Prices

01. June 2018 EHR, EMR, Health, HIPAA 0
Health and Human Services Secretary Alex Azar issued the following statement on the Food and Drug Administration’s announcement of two guidances regarding drug manufacturers’ use of shared risk evaluation and mitigation strategies: “HHS is taking more action on President Trump’s blueprint to put American patients first. The FDA’s announcement today will help generic drug manufacturers ...